Literature DB >> 8408290

Regulation of p53 protein expression in human breast cancer cell lines.

B Vojtĕsek1, D P Lane.   

Abstract

Mutation of the p53 gene is a common occurrence in human breast cancers but is by no means universal. However, even in tumours where the gene is not mutated altered levels of p53 protein are often detected. This is also observed in cell lines derived from human breast cancers. By transfecting such cell lines containing either wild type or mutant p53 genes with a temperature-sensitive mutant mouse p53 gene we have established that the cellular environment plays a critical role in the regulation of p53 protein expression. The results suggest that tumours that aberrantly express wild-type p53 may have lost the normal growth regulatory response to the protein and thus be functionally similar to those expressing the mutant protein.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8408290     DOI: 10.1242/jcs.105.3.607

Source DB:  PubMed          Journal:  J Cell Sci        ISSN: 0021-9533            Impact factor:   5.285


  27 in total

1.  Ionizing radiations increase the activity of the cell surface glycohydrolases and the plasma membrane ceramide content.

Authors:  Massimo Aureli; Rosaria Bassi; Alessandro Prinetti; Elena Chiricozzi; Brigida Pappalardi; Vanna Chigorno; Nadia Di Muzio; Nicoletta Loberto; Sandro Sonnino
Journal:  Glycoconj J       Date:  2012-05-17       Impact factor: 2.916

2.  Proteolytic cleavage of human p53 by calpain: a potential regulator of protein stability.

Authors:  M H Kubbutat; K H Vousden
Journal:  Mol Cell Biol       Date:  1997-01       Impact factor: 4.272

3.  Phytochemical regulation of the tumor suppressive microRNA, miR-34a, by p53-dependent and independent responses in human breast cancer cells.

Authors:  Kris G Hargraves; Lin He; Gary L Firestone
Journal:  Mol Carcinog       Date:  2015-03-19       Impact factor: 4.784

4.  Cytoplasmic sequestration of wild-type p53 protein impairs the G1 checkpoint after DNA damage.

Authors:  U M Moll; A G Ostermeyer; R Haladay; B Winkfield; M Frazier; G Zambetti
Journal:  Mol Cell Biol       Date:  1996-03       Impact factor: 4.272

Review 5.  On the expression of the p53 protein in human cancer.

Authors:  D P Lane
Journal:  Mol Biol Rep       Date:  1994-01       Impact factor: 2.316

6.  A novel p53 phosphorylation site within the MDM2 ubiquitination signal: II. a model in which phosphorylation at SER269 induces a mutant conformation to p53.

Authors:  Jennifer A Fraser; Arumugam Madhumalar; Elizabeth Blackburn; Janice Bramham; Malcolm D Walkinshaw; Chandra Verma; Ted R Hupp
Journal:  J Biol Chem       Date:  2010-09-16       Impact factor: 5.157

Review 7.  P53, apoptosis, and breast cancer.

Authors:  D M Barnes; R S Camplejohn
Journal:  J Mammary Gland Biol Neoplasia       Date:  1996-04       Impact factor: 2.673

8.  p53 abnormalities are rare events in neuroendocrine (Merkel cell) carcinoma of the skin. An immunohistochemical and SSCP analysis.

Authors:  M Schmid; K Janssen; B Dockhorn-Dworniczak; D Metze; B W Zelger; T A Luger; K W Schmid
Journal:  Virchows Arch       Date:  1997-03       Impact factor: 4.064

9.  Transcriptional targeting of gene expression in breast cancer by the promoters of protein regulator of cytokinesis 1 and ribonuclease reductase 2.

Authors:  Hye Jin Yun; Young-Hwa Cho; Youngsun Moon; Young Woo Park; Hye-Kyoung Yoon; Yeun-Ju Kim; Sung-Ha Cho; Young-Ill Lee; Bong-Su Kang; Wun-Jae Kim; Keerang Park; Wongi Seo
Journal:  Exp Mol Med       Date:  2008-06-30       Impact factor: 8.718

10.  Immunohistochemical analysis of p53 protein overexpression in liver cell dysplasia and in hepatocellular carcinoma.

Authors:  M Zhao; N X Zhang; J A Laissue; A Zimmermann
Journal:  Virchows Arch       Date:  1994       Impact factor: 4.064

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.